due to continued cyber security attacks we have had to close the store.

VOBIT 0.2 MG 15 Tablets

$7.25

Brand Name:  Vobit

Name:  Voglibose

Strength:   0.2 mg 

Pills per order:   15 Tablets

Production Company:  Lupin

Used for:  anti-diabetic medicines called alpha-glucosidase inhibitors used to treat type-2 diabetes mellitus.

Vobit  0.2  

Vobit 0.2 is an anti-diabetic medication classified as an alpha-glucosidase inhibitor. It is used to treat type-2 diabetes mellitus. Vobit 0.2 is used to treat type 2 diabetes in patients who are unable to regulate their blood sugar levels by diet and exercise alone.

Diabetes mellitus type 2 is also referred to as non-insulin-dependent diabetes. Diabetes is a disease in which blood glucose levels are elevated above normal. Insulin is the hormone that regulates blood sugar levels. Individuals with type 2 diabetes either produce insufficient insulin or the insulin produced is unable to accomplish its intended purpose in the body (insulin resistance). Individuals in their middle to late twenties or older are more likely to develop type 2 diabetes, often known as adult-onset diabetes.

Vobit 0.2 inhibits the intestinal enzymes that convert complex sugars to simple sugars such as glucose. As a result, it aids in keeping blood glucose levels from rapidly rising following meals.

Vobit 0.2 may be taken with or without food. The pill should not be chewed, broken, or crushed; it should be swallowed whole with a glass of water. Every day, take Vobit 0.2 at the same time. Vobit 0.2 should not be taken unless a doctor has prescribed it. It is recommended that you continue taking Vobit 0.2 for as long as your doctor prescribes it, depending on your medical condition. Certain common adverse effects may occur in some circumstances, including abdominal pain, diarrhea, flatulence (gas), skin reactions, heartburn, nausea, and vomiting. The majority of these adverse effects are temporary and will resolve on their own. However, you should visit your doctor if you continue to encounter any adverse effects.

To effectively treat your disease, continue taking Vobit 0.2 for the duration advised by your doctor. Please avoid skipping doses or abruptly stopping Vobit 0.2 without seeing your doctor, since this may result in elevated blood glucose levels. Unless otherwise advised, avoid using Vobit 0.2 if you are pregnant or breastfeeding. Vobit 0.2 should not be given to youngsters unless a doctor has prescribed it. Avoid alcoholic beverages while taking Vobit 0.2, since they may exacerbate negative effects. Inform your physician of the medications you are currently taking and your current health status to rule out any unwanted side effects.

Vobit 0.2 is used for the treatment of type-2 diabetes mellitus.

VOBIT 0.2 MG

Medicinal Advantages

Vobit 0.2 is a member of a class of anti-diabetic medications known as alpha-glucosidase inhibitors. Vobit 0.2 is used for the treatment of type-2 diabetes mellitus. Vobit 0.2 is used to treat type 2 diabetes in patients who are unable to regulate their blood sugar levels by diet and exercise alone. Vobit 0.2 inhibits the intestinal enzymes that convert complex sugars to simple sugars such as glucose. As a result, it aids in keeping blood glucose levels from rapidly rising following meals.

Use Instructions

Vobit 0.2 may be taken with or without food. The pill should not be broken, chewed, or crushed; it should be swallowed whole with a glass of water. Every day, take Vobit 0.2 at the same time. Vobit 0.2 should not be taken unless a doctor has prescribed it. Your doctor will determine the duration of your Vobit 0.2 treatment based on your medical condition.

Storage

Store in a cool, dry location away from direct sunlight.

Vobit 0.2 Adverse Reactions

As is the case with other medications, Vobit 0.2 may have negative effects, albeit not everyone experiences them. Vobit 0.2 is frequently associated with abdominal pain, diarrhea, flatulence (wind), skin problems, heartburn, nausea, and vomiting. Consult your doctor if any of these side effects persist.

Adverse Drug Reactions

Voglibose should not be given to patients with diabetic ketoacidosis, inflammatory bowel disease (IBD), intestine ulcers or partial intestinal obstructions, intestinal obstruction, or chronic disorders associated with digestion or absorption disorders, whose conditions may deteriorate as a result of increased gas formation in the intestine. Voglibose should be used with caution if you have intestinal difficulties, problems with digestion and absorption, or kidney or liver problems. To effectively treat your disease, continue taking Voglibose for the duration advised by your doctor. Please avoid skipping doses or abruptly stopping Voglibose without seeing your doctor, since this may result in elevated blood glucose levels. Unless otherwise advised, avoid using Voglibose if you are pregnant or breastfeeding. Voglibose should not be administered to children unless a doctor has prescribed it. Avoid alcoholic beverages while taking Voglibose, as they may exacerbate negative effects. Inform your physician of the medications you are currently taking and your current health status to rule out any unwanted side effects.

Interactions Between Drugs

INTERACTIONS BETWEEN DRUG CLASSES: Voglibose may interact with diabetes medications (metformin, insulin), aspirin, thyroid hormone (levothyroxine), anti-HIV medications (zidovudine), asthma medications (theophylline), and blood thinners (warfarin).

INTERACTIONS BETWEEN FOOD AND MEDICINE: Avoid alcohol consumption while taking Voglibose since it may produce unpleasant side effects.

INTERACTIONS WITH OTHER MEDICATIONS: Voglibose should not be given to patients with diabetic ketoacidosis, inflammatory bowel disease (IBD), intestine ulcers or partial intestinal obstructions, intestinal obstruction, or chronic disorders involving digestion or absorption, with conditions that may deteriorate as a result of increased gas formation in the intestine.

Safety Recommendations

ALCOHOL

To avoid undesirable side effects, it is recommended that you abstain from alcohol while taking Voglibose.

PREGNANCY

Consult your physician if you have any concerns; your physician will determine whether pregnant ladies can take or not.

BREAST FEEDING

Consult your physician if you have any worries about this; your physician will determine whether or not Voglibose can be administered to breast-feeding mothers.

DRIVING

Only operate machinery and drive if you are alert.

LIVER

Adjustment of the dose may be necessary. Voglibose should be taken cautiously in people with liver illness or impairment. Consult your physician if you have a liver impairment or have any concerns about this.

KIDNEY

Adjustment of the dose may be necessary. Voglibose should be taken cautiously in people with kidney disease or impairment. Consult your physician if you have kidney impairment or have any concerns about this.

No Habit Formation

Advice on Diet and Lifestyle

Consume foods that are high in nutritious carbs and fiber, such as fruits, whole grains, and vegetables.

Consume food in regular intervals. Avoid skipping meals. Additionally, avoid overeating.

Maintain a nutritious diet and walk for at least 45 minutes to complement your Voglibose medication.

Exercise regularly to maintain a healthy weight.

Maintain good rest and avoid stress through meditation or yoga.

Special Guidance

Monitor blood glucose levels frequently when using Voglibose.

Avoid missing any doses and continue taking Voglibose for the duration suggested by your doctor.

Keep your doctor informed of your current health/disease conditions and medications.

To effectively treat your disease, continue taking Voglibose for the duration advised by your doctor. Avoid abruptly discontinuing it, as this may result in elevated blood glucose levels.

Your doctor may encourage you to undergo routine liver function testing.

Additional Information (VOB0033): This item cannot be returned.

Concern for Patients

Diabetes mellitus type 2 is also referred to as non-insulin-dependent diabetes. It is a chronic or lifelong condition that impairs the body’s ability to appropriately utilize insulin. Diabetes is a disease in which blood glucose levels are elevated above normal. Insulin is the hormone that regulates blood sugar levels. Individuals with type 2 diabetes either produce insufficient insulin or the insulin produced is unable to accomplish its intended purpose in the body (insulin resistance). Individuals in their middle to late twenties or older are more likely to develop type 2 diabetes, often known as adult-onset diabetes. Lack of energy, fatigue, frequent urination, excessive thirst, dry mouth, blurred eyesight, persistent hunger, weight loss, and itchy skin are all symptoms of type 2 diabetes.

FAQs

Voglibose acts by blocking intestinal enzymes that convert complex carbohydrates to simple sugars such as glucose. As a result, it aids in keeping blood glucose levels from rapidly rising following meals.

When combined with other anti-diabetic medications, voglibose may produce hypoglycemia. Monitor your blood glucose levels frequently while using Voglibose to avoid hypoglycemia (low blood sugar levels).

Please do not abruptly discontinue taking Voglibose without consulting your doctor, since this may result in an increase in blood glucose levels. Continue to take Voglibose as directed by your doctor. Do not be afraid to contact your doctor if you have any problems while taking Voglibose.

Avoid alcohol consumption while taking Voglibose since it may exacerbate the drug’s negative effects.

If you are pregnant, do not take Voglibose unless your doctor prescribes it. Voglibose will be prescribed by your physician only if the benefits outweigh the hazards.

After the expiration date, do not use Voglibose. The term “expiry” refers to the last day on which the manufacturer guarantees the drug’s complete efficacy and safety. Periodically check the expiration date and properly discard Voglibose or return it to your pharmacist for proper disposal.

Additional information

Chemical Name

Reviews

There are no reviews yet.

Be the first to review “VOBIT 0.2 MG 15 Tablets”